We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

601811:SSEXinhua Winshare Publishing & Media Co., Ltd. Class A Analysis

Data as of 2026-07-16 - not real-time

CN¥12.09

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Xinhua Winshare is trading at CNY 12.09, comfortably above its 20‑day SMA of 11.44 but still below the 200‑day SMA of 13.79, indicating a short‑term pull‑back within a longer‑term downtrend. The RSI sits around 56, suggesting neutral momentum, while the MACD histogram is positive despite a negative MACD line, hinting at a tentative bullish divergence. Valuation metrics are attractive – a trailing PE of 9.5x versus an industry average of 16.5x, a price‑to‑book under 1.0, and a dividend yield of 5 % with a payout ratio under 50%. However, the DCF‑derived fair value of 10.23 is below the current price, and the stock faces a clear resistance at 12.13 and support at 10.71. Volatility is elevated at roughly 28 % over the past month, beta is low at 0.165, and trading volume has been trending down, raising liquidity concerns. The company’s balance sheet is strong, featuring ample cash, modest debt, and positive free cash flow, supporting the sustainability of its dividend. Overall, the stock presents a value‑oriented case with solid income potential but carries medium‑term technical weakness and liquidity risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish technical trend with price near resistance
  • High dividend yield offering income cushion
  • Decreasing trading volume reducing short‑term liquidity

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued relative to peers (low PE and PB)
  • Strong cash position and manageable debt
  • Sustainable dividend supporting total return

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Low beta and defensive sector characteristics
  • Consistent dividend income over time
  • Value orientation with room for price appreciation if market sentiment improves

Key Metrics & Analysis

Financial Health

Revenue Growth-0.20%
Profit Margin13.35%
P/E Ratio9.5
ROE10.32%
ROA2.95%
Debt/Equity2.29
P/B Ratio1.0
Op. Cash FlowCN¥1.1B
Free Cash FlowCN¥345.0M
Industry P/E16.5

Technical Analysis

TrendBearish
RSI56.4
SupportCN¥10.71
ResistanceCN¥12.13
MA 20CN¥11.44
MA 50CN¥12.36
MA 200CN¥13.79
MACDBullish
VolumeDecreasing
Fear & Greed Index93.45

Valuation

Fair ValueCN¥10.23
GradeFair
TypeValue
Dividend Yield5.05%

Risk Assessment

Beta0.52
Volatility27.84%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.